INTRODUCTION
The drawn of a post-antibiotic era is almost upon us. New challenges for the control of diseases caused by pathogenic microbes to our present day antibiotics and reemergence of devastating diseases such as pyoderma (literally means pus in the skin and refers to bacterial infections of the skin) leads one to conclude that new strategies to combat these disease causing microorganisms must be developed with great deal of urgency 1 .
Previous work by the medicinal chemists had led to a number of drugs related uses being found for benzoxazinone class of heterocyclic compounds. The family of benzoxazinones was found promising as antifungal and antibacterial agents [2] [3] [4] [5] [6] [7] . Benzoxazinone derivatives are used as antiphlogistic drugs 8 . They have also shown antielastase properties 9 . Recently this class of compounds reported to show a strong dual inhibitory effect on human neutrophil elastase release 10 . Fenton et al. 11 have described plasma lipid altering characteristics of a series of substituted 4H-3,1-benzoxazin-4-one as high density lipoprotein elevators for the treatment of patients suffering from hyperlipoproteinemia and associated diseases. Beside of their TLC, which was performed on 2.0 × 5.0 cm aluminum sheets precoated with silica gel 60F254 to a thickness of 0.25 mm (Merck). The chromatograms were visualized under ultraviolet light (254-366 nm) or iodine vapours. All the carboxylic acids are commercially available (Flulka Aldrich).
Synthesis of 2-aryl-4H-3,1-benzoxzin-4-one (3a-3t) 16 : To a 100 mL round bottom flask containing the solution of anthranilic acid (1.37 g, 0.01 mol) in pyridine (30 mL) was cooled to 0 ºC in an ice bath followed by the careful addition of acid chlorides (2a-2s) (0.02 mol). An exothermic reaction occurred. The reaction mixture was stirred for 5 min at 0 ºC. The ice bath was removed and the reaction mixture was allowed to warm slowly to room temperature. The reaction mixture was further stirred for 0.5 h at room temperature. The reaction mixture was poured into ice cold water (200 mL) and precipitates were filtered off. The residue was washed with cold water (3 × 60 mL) and dried. Benzoxazin-4-one crystallized from ethanol as white prismatic needles. 4-Methyl-N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]benzenesulfonamide (3t) was also synthesized with similar procedure 17 in which p-toluene sulphonyl chloride was used instead of acid chloride. 
2-Phenyl-4H-3,1-benzoxazin-4-one (3a):

2-(2-Methoxyphenyl)-4H-3,1-benzoxazin-4-one (3p):
Yield: 75 % (1.9 g, 7.5 mmol); m.p.: 131 ºC (lit. 17 Antibacterial bioassay: Bactericidal activity was determined by agar well diffusion method 19 . This test was performed by spreading 18-24 h old pathogenic bacterial culture of all six bacterial starins viz. Bacillus subtilis, Pseudomonas aeruginsoa, Staphylococcus aureus, Shigella Flexnari, Escherichia coli and Salmonella typhi containing approximately 10 4 -10 6 colony forming units (CFU)/mL on the surface of nutrient agar plates. The bacterial cells were counted by hemocytometer method under microscope. In nutrient agar plate wells of 0.85 cm size were produced with the help of sterilized metallic borer under aseptic condition in laminar flow chamber. Twenty test samples after microfiltration with 0.2 microns filters in concentrations (100 µg) in DMSO were added in labeled wells. Other wells were supplemented with reference drugs i.e. Amoxycillin, Streptomycin and Kanamycin were used as standard reference drugs (100 µg) serving as the positive controls. The ciprofloxacin was used as a reference standard (5 µg) in DMSO for Pseudomonas aeruginsoa. DMSO was also used for the preparation of solutions of standard antibiotics used in the current experimental assay. Experimental plates after spreading the bacterial strains on the separate plates along subsequent addition of the drugs and samples in the wells were subjected to incubation at 37 ºC for 24 h and bacterial growth was determined by measuring the diameter of zone of inhibition in mm. During antibacterial assay negative control wells were also used where pure solvents were used instead of the compounds. The experiment was repeated thrice and the mean values are recorded to evaluate the antibacterial potential of synthesized compounds with reference to positive and negative controls.
RESULTS AND DISCUSSION
One mole equivalent of anthranilic acid (1) was treated with two mole equivalent of aryl chlorides (2a-2s) in the presence of excess of pyridine to give 2-substituted benzoxazin-4-one (3a-3s) in moderate to excellent 16 yields (Scheme-I). The acid chlorides, where not commercially available, were prepared by the action of thionyl chloride on the appropriate carboxylic acid. The failure of aliphatic acyl halides to produce benzoxazinones is probably due to ready hydrolysis of initially formed 2-alkyl-4H-3,1-benzoxazin-4-one 18 Anthranilic acid (1) reacts with p-toluene-sulphonyl chloride (2t) in the presence of excess of pyridine to give 2substituted benzoxazin-4-one (3t) in good yield. This reaction probably proceeds via a mixed carboxylic acid-sulphonic acid anhydride intermediate (Scheme-II). Antibacterial activity: The antibacterial activity of twenty compounds was assayed in vitro by agar well diffusion method 19 against six bacterial species. Among them four were gram negative and two were Gram positive bacteria. The results of bactericidal activities were displayed in Tables 1 and 2 . Most of compounds showed the bactericidal activities against four strains of Gram negative bacteria (Table-1 ). The compounds 3a, 3d, 3k, 3r and 3t had shown no bactericidal activity against any bacteria (Tables 1 and 2) . The compounds 3f, 3s, 3p, 3m and 3b showed good to moderate activity against Shigella flexnari. The compounds 3b, 3e, 3g, 3i and 3p showed weak activity against Escherichia coli. The compound 3n showed good activity against Pseudomonas aeruginsoa, whereas other compounds 3b, 3c, 3e, 3f, 3l, 3s, 3p, 3o and 3q showed moderate to weak activity in comparison to standard ciprofloxacin. The compound 3b and 3h showed some activity against Salmonella typhi. The remaining compounds were inactive against all microorganisms. A comparison of bactericidal activity of 2-aryl-4H-3,1benzoxazinones with three reference antibiotics is shown in Table- 2. Two compounds 3o and 3s with o-bromophenyl and 1-naphthyl moieties showed weak activity against Staphylococcus aureus (Table-2 ). All compounds were inactive against Bacillus subtilis except compound 3f with m-nitrophenyl group demonstrated significant activity in comparison to reference standard antibiotics (Table-2 ).
Conclusion
Twenty derivatives of 2-aryl-4H-3,1-benzoxazin-4-ones were synthesized and evaluated for bactericidal activity against six pathogenic microorganism. In conclusion, 2-aryl-4H-3,1benzoxazin-4-ones possess a broad spectrum of activity against a group of Gram negative bacteria responsible causing most common bacterial diseases. However, few members were active against Gram positive bacteria. This study opens the possibility of finding new clinically effective bactericidal compounds.
